Jeffrey Frelinger

Dr. Jeffrey Frelinger

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2013 in Genes & Immunity
Verified
Journal Article
Open access
PDF file
JPJ Phillippi
J Phillippi
YXY Xie
Y Xie
DMD R Miller
D R Miller
TBT A Bell
T A Bell
ZZZ Zhang
Z Zhang
JFJeffrey Frelinger
Jeffrey Frelinger
The Collaborative Cross (CC) is an emerging panel of recombinant inbred (RI) mouse strains. Each strain is genetically distinct but all descended from the same eight inbred founders. In 66 strains from incipient lines of the CC (pre-CC), as well as the 8 CC founders and some of their F1 offspring, we examined subsets of lymphocytes and antigen-presenting cells. We found significant variation among the founders, with even greater diversity in the pre-CC. Genome-wide association using inferred haplotypes detected highly significant loci controlling B-to-T cell ratio, CD8 T-cell numbers, CD11c and CD23 expression. Comparison of overall strain effects in the CC founders with strain effects at QTL in the pre-CC revealed sharp contrasts in the genetic architecture of two traits with significant loci: variation in CD23 can be explained largely by additive genetics at one locus, whereas variation in B-to-T ratio has a more complex etiology. For CD23, we found a strong QTL whose confidence interval contained the CD23 structural gene Fcer2a. Our data on the pre-CC demonstrate the utility of the CC for studying immunophenotypes and the value of integrating founder, CC and F1 data. The extreme immunophenotypes observed could have pleiotropic effects in other CC experiments.

22 November 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
AHAmy P. Hsu
Amy P. Hsu
AKAgnieszka Korzeniowska
Agnieszka Korzeniowska
CACynthia C. Aguilar
Cynthia C. Aguilar
JGJingwen Gu
Jingwen Gu
EKEric Karlins
Eric Karlins
SHSteven M. Holland
Steven M. Holland
Disseminated coccidioidomycosis (DCM) is caused by Coccidioides , pathogenic fungi endemic to the southwestern United States and Mexico. Illness occurs in approximately 30% of those infected, less than 1% of whom develop disseminated disease. To address why some individuals allow dissemination, we enrolled patients with DCM and performed whole-exome sequencing. In an exploratory set of 67 patients with DCM, 2 had haploinsufficient STAT3 mutations, and defects in β-glucan sensing and response were seen in 34 of 67 cases. Damaging CLEC7A and PLCG2 variants were associated with impaired production of β-glucan–stimulated TNF-α from PBMCs compared with healthy controls. Using ancestry-matched controls, damaging CLEC7A and PLCG2 variants were overrepresented in DCM, including CLEC7A Y238* and PLCG2 R268W. A validation cohort of 111 patients with DCM confirmed the PLCG2 R268W, CLEC7A I223S, and CLEC7A Y238* variants. Stimulation with a DECTIN-1 agonist induced DUOX1/DUOXA1–derived hydrogen peroxide [H 2 O 2 ] in transfected cells. Heterozygous DUOX1 or DUOXA1 variants that impaired H 2 O 2 production were overrepresented in discovery and validation cohorts. Patients with DCM have impaired β-glucan sensing or response affecting TNF-α and H 2 O 2 production. Impaired Coccidioides recognition and decreased cellular response are associated with disseminated coccidioidomycosis.

2 July 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MSMegan J. Smithey
Megan J. Smithey
VVVanessa Venturi
Vanessa Venturi
MDMiles P. Davenport
Miles P. Davenport
ABAdam Scott Buntzman
Adam Scott Buntzman
BVBenjamin G. Vincent
Benjamin G. Vincent
JNJanko Nikolich-Žugich
Janko Nikolich-Žugich
Lifelong interactions between host and the ubiquitous and persistent cytomegalovirus (CMV) have been proposed to contribute to the age-related decline in immunity. Prior work from us and others found some support for that idea, yet evidence that this led to increased vulnerability to other infections was not obtained. Moreover, evidence has accumulated that CMV infection can be beneficial to immune defense in young/adult mice and humans, dominantly via enhanced innate immunity. Here, we describe an unexpected impact of murine CMV (MCMV) upon the T cell response of old mice to Listeria monocytogenes expressing the model antigen, OVA (Lm-OVA). Single-cell sequencing of the OVA-specific CD8 T cell receptor β (TCRβ) repertoire of old mice demonstrated that old MCMV-infected mice recruited many diverse clonotypes that afforded broad and often more efficient recognition of antigenic peptide variants. This stood in contrast to old control mice, which exhibited strong narrowing and homogenization of the elicited repertoire. High-throughput sequencing of the total naïve CD8 TCRβ repertoire showed that many of these diverse OVA-specific clonotypes were present in the naïve CD8 repertoire of mice in all groups (adult, old control, and old MCMV+) yet were only recruited into the Lm-OVA response in MCMV+ old mice. These results have profound implications for our understanding of T cell immunity over a life span and suggest that our coevolution with CMV may include surprising, potentially positive impacts on adaptive heterologous immunity in late life. Significance Epidemiological studies have shown a correlation between CMV infection and immune system aging, especially in elderly populations. It remains unclear whether CMV infection is a key driver of, or simply a factor associated with, aging of the immune system. We show that aging in the presence of lifelong CMV infection improves T cell immunity in old animals by broadening the immune response to a different pathogen. Animals that have aged with CMV are able to recruit novel T cells into these immune responses that are present in, but not utilized in, animals aging without CMV. These data squarely challenge the premise that CMV is solely detrimental to the aging of the adaptive immune system.

1 June 2014 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
LRLydia M. Roberts
Lydia M. Roberts
STShraddha Tuladhar
Shraddha Tuladhar
SSShaun P. Steele
Shaun P. Steele
KRKristina J. Riebe
Kristina J. Riebe
CCChing-Ju Chen
Ching-Ju Chen
JFJeffrey Frelinger
Jeffrey Frelinger
The adaptive immune response to Francisella tularensis is dependent on the route of inoculation. Intradermal inoculation with the F. tularensis live vaccine strain (LVS) results in a robust Th1 response in the lungs, whereas intranasal inoculation produces fewer Th1 cells and instead many Th17 cells. Interestingly, bacterial loads in the lungs are similar early after inoculation by these two routes. We hypothesize that the adaptive immune response is influenced by local events in the lungs, such as the type of cells that are first infected with Francisella . Using fluorescence-activated cell sorting, we identified alveolar macrophages as the first cell type infected in the lungs of mice intranasally inoculated with F. novicida U112, LVS, or F. tularensis Schu S4. Following bacterial dissemination from the skin to the lung, interstitial macrophages or neutrophils are infected. Overall, we identified the early interactions between Francisella and the host following two different routes of inoculation.

6 April 2018 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
LRLydia M. Roberts
Lydia M. Roberts
DPDaniel A. Powell
Daniel A. Powell
JFJeffrey Frelinger
Jeffrey Frelinger
Francisella tularensis is an intracellular bacterium that causes the disease tularemia. There are several subspecies of F. tularensis whose ability to cause disease varies in humans. The most virulent subspecies, tularensis, is a Tier One Select Agent and a potential bioweapon. Although considerable effort has made to generate efficacious tularemia vaccines, to date none have been licensed for use in the United States. Despite the lack of a tularemia vaccine, we have learned a great deal about the adaptive immune response the underlies protective immunity. Herein, we detail the animal models commonly used to study tularemia and their recapitulation of human disease, the field's current understanding of vaccine-mediated protection, and discuss the challenges associated with new vaccine development.

1 June 2014 in Vaccine
Verified
Journal Article
Closed access
LRLydia M. Roberts
Lydia M. Roberts
JDJohn S. Davies
John S. Davies
GSGregory D. Sempowski
Gregory D. Sempowski
JFJeffrey Frelinger
Jeffrey Frelinger